|
Market Cap (24-May) $65,067,412 (361st) |
Close (30-Jun) $0.100 |
Volume (30-Jun) 1,754,344 |
Shortsold (29-Nov) 5,010,077 (0.32%) (345th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -1.3 |
IHL released this announcement to the ASX on 11 August 2021, 8:19. The announcement is marked as price sensitive, and is 14 page(s) in length and 1.12MB in size.
You can view all announcements from IHL and see how they appear on a price chart on the announcements page.
At the date of this announcement, IHL was 0.013% short sold according to ASIC data. It was ranked the 557th most shorted stock on the ASX. It is now ranked as the 345th most shorted stock on the ASX with 0.316% of total shares short sold as of the latest reported data (29 November 2023).
| Other Recent Announcements from IHL | |
|---|---|
| Change of Director's Interest Notice | 30 June 2023, 13:57 |
| Change of Registered Office | 26 June 2023, 15:51 |
| IHL Announcement - H.C. Wainwright Virtual Conference | 23 June 2023, 8:17 |
| Incannex Psychedelic Therapies Presentation | 11 August 2021, 8:19 |
| HREC and FDA pre-IND request for Psilocybin Therapy | 10 August 2021, 8:15 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30 July 2021, 8:21 |
| IHL commences IHL-675A trial and patent application | 27 July 2021, 8:23 |
You must be logged in to post a reply.
Incannex Healthcare 